Health insurers have a unique opportunity to leverage Healthtech startups. This report series looks at a cross-section of interesting companies across a spectrum defined by our parent company Oliver Wyman's Health and Life Sciences practice. This is the first in a series of five reports from and authored by Celent.
In the series we will delve into four topic areas:
- Care Delivery
- Consumer Engagement
- Tech and Funding
- Science of Medicine
In each area, we will look at a variety of healthtech firms delivering interesting and useful technology to improve each functional area. There are literally thousands of these companies, which is encouraging for our industry. Clearly we will look at a cross-section.
As always, feedback is welcome!
